Emergent BioSolutions Aktie
6,92
EUR
-0,05
EUR
-0,72
%
8,01
USD
-0,06
USD
-0,74
%
Emergent BioSolutions jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Emergent BioSolutions Aktie Analyse
| 03.08.18 | Emergent BioSolutions Buy | Chardan Capital Markets | |
| 16.01.18 | Emergent BioSolutions Buy | Chardan Capital Markets | |
| 28.06.16 | Emergent BioSolutions Buy | Singular Research | |
| 15.04.16 | Emergent BioSolutions Buy | Chardan Capital Markets | |
| 28.03.16 | Emergent BioSolutions Buy | Singular Research | |
| 11.01.11 | Emergent BioSolutions outperform | Wedbush Morgan Securities Inc. | |
| 04.11.08 | Emergent BioSolutions | Global Biotech Investing |
Werbung
Werbung